Moreover, inhibition of IL-1 biological activity with use of an IL-1 receptor antagonist in a rat LI in vitro model also resulted in an improved phenotypic outcome with reduction of hyperkeratosis (45). Here, IL1B is linked to Hyperkeratosis.